Latest stories on IMRX
Immuneering: A Third (Much Cheaper) Way To Invest In The RAS-RAF-MEK-ERK 'Revolution'
Seeking Alpha73 · bullishproduct/pr
Immuneering Corporation Announces Grants of Inducement Awards | IMRX Stock News
StockTitan50 · neutralgeneral
Immuneering Corporation Announces Grants of Inducement Awards
Business Insider50 · neutralgeneral
Immuneering Appoints Veteran Biotech Leader as New CFO
TipRanks56 · neutralgeneral
Immuneering Corp (IMRX) files 8-K
SEC 8-K50 · neutralgeneral
Immuneering Appoints Andrew Gengos as Chief Financial Officer | IMRX Stock News
StockTitan56 · neutralgeneral
Immuneering Corp (IMRX) files 8-K
SEC 8-K50 · neutralgeneral
Immuneering Advances Atebimetinib With Positive Phase 2a Results
TipRanks67 · bullishproduct/pr
Immuneering Corporation (IMRX) Discusses Positive Atebimetinib ASCO Data Update in First-Line Pancreatic Cancer Transcript
Seeking Alpha73 · bullishproduct/pr
Immuneering’s Atebimetinib Combo Delivers 17.3-Month Median Overall Survival in First-Line Metastatic Pancreatic Cancer—What Sets This Result Apart?
MarketChameleon73 · bullishproduct/pr
Immuneering GAAP EPS of -$0.21 beats by $0.04
Seeking Alpha56 · neutralearnings
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
Business Insider56 · neutralearnings